#AHSCT
aHSCT is being used in many places . If it’s given in the early stages of MS , it can be very effective .
June 22, 2026 at 4:07 PM
Transplantationen eigener Blutstammzellen können bei besonders aggressiver Form von Multipler Sklerose helfen! Erste "real world"-Daten sind jedenfalls vielversprechend: jnnp.bmj.com/content/earl... 🧪
Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK
Background Autologous haematopoietic stem cell transplantation (AHSCT) is increasingly used as a one-off disease-modifying therapy for aggressive forms of multiple sclerosis (MS). We report real-world...
jnnp.bmj.com
September 8, 2025 at 10:41 AM
My first #AHSCT patient: 25 years of NEDA-3. No relapses, no MRI activity, improved EDSS, no DMTs.
75% of RRMS patients treated with BEAM+ATG at CReSM San Luigi (Orbassano) are in #NEDA-3.
This opportunity must reach more patients. AHSCT needs to be a research priority.
🔗 Visit curems.net
#AHSCT #MS
March 18, 2026 at 8:30 AM
Thank you to @gavingiovannoni.bsky.social for writing this over 2 years ago. Thought provoking and will contribute to my discussions with my neuro.

#MS #AHSCT #CAR-T-Cell

gavingiovannoni.substack.com/p/ahsct-vs-c...
AHSCT vs. CAR T-cells to treat MS
Do we have to use AHSCT an immunological sledgehammer to treat MS? Can't we use something simpler like a targeted immunotherapy or an antiviral to control EBV?
gavingiovannoni.substack.com
January 14, 2026 at 3:44 PM
Step 2 of aHSCT planning/implementation in the diary. New immune system please 🙏🏼 #MS #AHSCT
March 9, 2026 at 5:48 PM
Pencilled in, 6 weeks tomorrow, Day -7, stem cell transplant conditioning will start.

Meaning Sept 21st, Day 0, I should get my stem cells back.

#aHSCT #Lymphoma #CurativeIntent #NeverGiveUp
August 2, 2026 at 8:58 PM
Has anyone here gone through AHSCT treatment for #multiplesclerosis #ms do you mind sharing your experience with me? #chronicillness
November 28, 2024 at 6:20 AM
Skin disease management in SSc: I made a summary of the wonderful lecture by Dr. Domsic. #ACR2024 #Rheumsky
Not included here: management of xerosis and increased skin sensitivity: moisturize+ consider antihistamines+ consider gabapentin/pregabalin.
Added AHSCT to the table.
December 24, 2024 at 4:19 PM
I was thinking the same, like AHSCT. I've all my fingers and toes crossed for you.
May 7, 2026 at 12:27 PM
Next MRI's booked in for pre-empting #AHSCT treatment for #MS. I doubt I'll meet the eligibility criteria, but let's allow #CharingCross Hospital to make that decision. Happy Christmas everyone, let 2026 bring stem cell transplantation! 🙏🏼😊😂
December 24, 2025 at 1:40 PM
I’m very excited to share our results on autologous hematopoietic stem cell transplantation ( #AHSCT ) in #MS from #Hamburg and #Heidelberg in the Journal of Neurology, Neurosurgery & Psychiatry. Grateful to all colleagues who made this work possible!
#INIMS

jnnp.bmj.com/content/earl...
jnnp.bmj.com
May 7, 2026 at 3:52 PM
Day 9 of #aHSCT and I'm hooked up to the apheresis machine. I'm on course to hit the required 2,000,000 stem cells #multiplesclerosis #ms
January 29, 2025 at 11:04 AM
I've elected to use BlueSky as a repository for my thoughts and experiences as I document what aHSCT (stem cell) treatment for an MS patient is like in 2025.

My plan is to also video my journey & upload to Youtube to help others in a similar position! :)
November 17, 2024 at 5:44 AM
📢 Great publication by our Fellow @felixfischbach.bsky.social! His study shows that autologous haematopoietic stem cell transplantation (aHSCT) can provide sustained disease stability in MS, especially in RRMS, with potential benefits for progressive MS 🧠🔬 #HertieNetwork
jnnp.bmj.com/content/earl...
Autologous haematopoietic stem cell transplantation in multiple sclerosis: outcomes and predictors from German real-world data
Background Autologous haematopoietic stem cell transplantation (aHSCT) represents a treatment option for highly aggressive multiple sclerosis (MS). Here, we report outcome analyses from the two larges...
jnnp.bmj.com
July 3, 2026 at 11:10 AM
🎉 curems.net turns one!
In 12 months:
🟢 40% Italian, 60% international readers
🟢 1,250+ contacts from 56 countries
🟢 152 scientific papers cited
🟢 Biweekly updates
CureMS.net is becoming a key resource on #AHSCT for patients and professionals. Thanks to all who support and to all the readers! #MS
October 23, 2025 at 7:42 AM
DLBCLに対するHDC/AHSCTって何?
January 10, 2024 at 1:27 PM
Wow

That’s a long time given your treatment choice. When did you get approval for aHSCT?
April 9, 2026 at 5:20 AM
ICYMI: New online! Real-world effectiveness of stem cell transplantation for multiple sclerosis
Real-world effectiveness of stem cell transplantation for multiple sclerosis
Nature Reviews Neurology, Published online: 07 October 2025; doi:10.1038/s41582-025-01157-9Autologous haematopoietic stem cell transplantation (AHSCT) offers effective therapy for people with multiple sclerosis (MS), according to new real-world data.
bit.ly
October 13, 2025 at 7:07 PM
Stem Cell Transplantation vs. Alemtuzumab and Ocrelizumab for Relapsing Multiple Sclerosis
New England Journal of Medicine
In a real-world cohort study, patients who underwent AHSCT had lower rates of relapse than those who received either disease-modifying therapy.
go.psychconcierge.com
July 18, 2025 at 8:16 PM
Welcome to curems.net, an Evidence-based, nonprofit resource on Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for MS. 
🟢 Free, updated, downloadable materials on transplant.
🟢 Providing reliable information to guide patients and healthcare professionals.  
📌 Visit curems.net
May 19, 2025 at 3:01 PM
ICYMI: New online! Real-world effectiveness of stem cell transplantation for multiple sclerosis
Real-world effectiveness of stem cell transplantation for multiple sclerosis
Nature Reviews Neurology, Published online: 07 October 2025; doi:10.1038/s41582-025-01157-9Autologous haematopoietic stem cell transplantation (AHSCT) offers effective therapy for people with multiple sclerosis (MS), according to new real-world data.
bit.ly
October 8, 2025 at 7:06 PM
New JNNP study: In aggressive #RRMS, AHSCT greatly reduced PIRA: 10% over 10 years vs 49% in patients moving from natalizumab to other DMTs. Findings suggest #AHSCT may target the silent, smoldering processes that drive MS progression.
🟢More on AHSCT and MS at curems.net
November 25, 2025 at 7:08 AM
I've been waiting over 10 weeks so far since my pre aHSCT MRI's. I've chased MS nurses and Neurologist twice. Nothing.
April 8, 2026 at 8:11 PM